Specialists prefer treatments over surveillance for low-risk prostate cancer

the ONA take:

Specialists who treat prostate cancer agree that active surveillance is an effective treatment option; however, they do not recommend it for their own patients. In fact, most specialists prefer treatments performed by their own specialty. For example, urologists are more likely to recommend surgery and radiation oncologists are more likely to recommend radiation therapy. Prostate cancer typically progresses slowly, and many older men with the disease are likely to die of some other cause rather than their cancer. When asked to make a recommendation for a hypothetical 60-year-old man, just 22% would recommend active surveillance. The researchers suggest coordinated, multidisciplinary care involving the patient’s primary care providers as well as specialists may provide a more balanced approach to discussing treatment options.

Specialists recommend treatments performed by their specialty rather than active surveillance for lo
Specialists recommend treatments performed by their specialty rather than active surveillance for lo
Specialists who treat prostate cancer agree that active surveillance is an effective option - yet most don't recommend it when appropriate for their own patients, according to a study in the July issue of Medical Care. Rather, urologists are more likely to recommend surgery and radiation oncologists are more likely to recommend radiation therapy - the treatments provided by their own specialties.
READ FULL ARTICLE From Medical News Today
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs